Baxter has acquired SuppreMol for EUR 200 million (approximately $225M USD) before working capital and other adjustments Read the full story

Baxter International gave kidney drug developer Rockwell Medical a big boost in the form of $45 million in graduated payments in a biotech partnership. Read the full story

Baxter International had entered into an exclusive pharma licensing and collaboration agreement with Merrimack Pharmaceuticals to develop and commercialize lead cancer drug MM-398. Read the full story

Big pharma, Baxter International has entered into a definitive agreement to sell its two commercially marketed vaccines and related production facilities to Pfizer for a total cash consideration of $635 million, subject to certain adjustments. Read the full story

In today's m&a news, Baxter International announced the acquisition of AesRx. Read the full story

The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story

Baxter is a top pharmaceutical company based in Deerfield, Illinois, USA Read the full story

Baxter International has agreed for merger & acquisition for Chatham Therapeutics for $70 million. Read the full story

Big Pharma, Baxter International announced plans to create two separate, independent global healthcare companies -- one focused on developing and marketing innovative biopharmaceuticals and the other on life-saving medical products. Read the full story

Baxter International has restructured its ongoing biotech deal with Xenetic Bioscience for the development of BAX 826 to assess its potential to extend the half-life and duration of effectiveness.

Read the full story